APOE genotypes differentially remodel the astrocytic lipid droplet proteome to shape lipid droplet dynamics
- Carla Cuní-López
- Jessica T. Root
- Ying Hao
- Niek Blomberg
- Sascha J. Koppes-den Hertog
- Dylan Sacks
- Amber E. Trujillo
- Rodolfo Ghirlando
- Isabelle Kowal
- Jacob Epstein
- Linda G. Yang
- Mark R. Cookson
- Elise Marsan
- Rik van der Kant
- Martin Giera
- Yue Andy Qi
- Priyanka S. Narayan
2026-08-19
Lipid droplets are dynamic cellular organelles that store neutral lipids and coordinate metabolic and stress-response pathways. In the brain, lipid droplets in glial cells, including astrocytes, have been implicated in Alzheimer’s disease, but how genetic risk factors influence their composition and turnover remains poorly understood. APOE is the strongest genetic modulator of late-onset Alzheimer’s disease and exists in common variants that confer decreased, neutral, or increased risk. Here we show that APOE genotype shapes the lipid droplet proteome, lipidome, and degradation dynamics in human induced pluripotent stem cell-derived astrocytes. By comparing oleic acid-treated astrocytes carrying APOE2 , APOE3 , or APOE4 , we find that each variant is associated with distinct lipid droplet proteins and lipids. These molecular differences correspond to genotype-dependent changes in lipophagy, an autophagy-mediated pathway for lipid droplet clearance. Lipid droplets in APOE2 astrocytes undergo efficient autophagic turnover, whereas those in APOE4 astrocytes resist degradation. These findings identify impaired lipid droplet clearance as a potential mechanism linking APOE4 to Alzheimer’s disease risk.